168 related articles for article (PubMed ID: 35742959)
1. Hypomethylation of
Maesaka F; Kuwada M; Horii S; Kishi S; Fujiwara-Tani R; Mori S; Fujii K; Mori T; Ohmori H; Owari T; Miyake M; Nakai Y; Tanaka N; Bhawal UK; Luo Y; Kondoh M; Fujimoto K; Kuniyasu H
Int J Mol Sci; 2022 Jun; 23(12):. PubMed ID: 35742959
[TBL] [Abstract][Full Text] [Related]
2. Claudin-4: A New Molecular Target for Epithelial Cancer Therapy.
Fujiwara-Tani R; Mori S; Ogata R; Sasaki R; Ikemoto A; Kishi S; Kondoh M; Kuniyasu H
Int J Mol Sci; 2023 Mar; 24(6):. PubMed ID: 36982569
[TBL] [Abstract][Full Text] [Related]
3. Role of Nuclear Claudin-4 in Renal Cell Carcinoma.
Owari T; Sasaki T; Fujii K; Fujiwara-Tani R; Kishi S; Mori S; Mori T; Goto K; Kawahara I; Nakai Y; Miyake M; Luo Y; Tanaka N; Kondoh M; Fujimoto K; Kuniyasu H
Int J Mol Sci; 2020 Nov; 21(21):. PubMed ID: 33172177
[TBL] [Abstract][Full Text] [Related]
4. Claudin-4 overexpression is associated with epigenetic derepression in gastric carcinoma.
Kwon MJ; Kim SH; Jeong HM; Jung HS; Kim SS; Lee JE; Gye MC; Erkin OC; Koh SS; Choi YL; Park CK; Shin YK
Lab Invest; 2011 Nov; 91(11):1652-67. PubMed ID: 21844869
[TBL] [Abstract][Full Text] [Related]
5. Claudin-3 and claudin-4 regulate sensitivity to cisplatin by controlling expression of the copper and cisplatin influx transporter CTR1.
Shang X; Lin X; Manorek G; Howell SB
Mol Pharmacol; 2013 Jan; 83(1):85-94. PubMed ID: 23053666
[TBL] [Abstract][Full Text] [Related]
6. Regulation of the Epithelial-Mesenchymal Transition by Claudin-3 and Claudin-4.
Lin X; Shang X; Manorek G; Howell SB
PLoS One; 2013; 8(6):e67496. PubMed ID: 23805314
[TBL] [Abstract][Full Text] [Related]
7. Tight junction proteins claudin-3 and claudin-4 control tumor growth and metastases.
Shang X; Lin X; Alvarez E; Manorek G; Howell SB
Neoplasia; 2012 Oct; 14(10):974-85. PubMed ID: 23097631
[TBL] [Abstract][Full Text] [Related]
8. DNA-methylation-dependent alterations of claudin-4 expression in human bladder carcinoma.
Boireau S; Buchert M; Samuel MS; Pannequin J; Ryan JL; Choquet A; Chapuis H; Rebillard X; Avancès C; Ernst M; Joubert D; Mottet N; Hollande F
Carcinogenesis; 2007 Feb; 28(2):246-58. PubMed ID: 16829686
[TBL] [Abstract][Full Text] [Related]
9. Claudin-4-adhesion signaling drives breast cancer metabolism and progression via liver X receptor β.
Murakami-Nishimagi Y; Sugimoto K; Kobayashi M; Tachibana K; Kojima M; Okano M; Hashimoto Y; Saji S; Ohtake T; Chiba H
Breast Cancer Res; 2023 Apr; 25(1):41. PubMed ID: 37059993
[TBL] [Abstract][Full Text] [Related]
10. DNA demethylation of claudin-4 suppresses migration and invasion in laryngeal squamous carcinoma cells.
Liu Y; Chang K; Fu K; Dong X; Chen X; Liu J; Cui N; Ni J
Hum Pathol; 2018 May; 75():71-80. PubMed ID: 29447921
[TBL] [Abstract][Full Text] [Related]
11. Crucial roles of Sp1 and epigenetic modifications in the regulation of the CLDN4 promoter in ovarian cancer cells.
Honda H; Pazin MJ; Ji H; Wernyj RP; Morin PJ
J Biol Chem; 2006 Jul; 281(30):21433-21444. PubMed ID: 16714763
[TBL] [Abstract][Full Text] [Related]
12. TGFBR3 co-downregulated with GATA3 is associated with methylation of the GATA3 gene in bladder urothelial carcinoma.
Liu XL; Xue BX; Lei Z; Yang DR; Zhang QC; Shan YX; Zhang HT
Anat Rec (Hoboken); 2013 Nov; 296(11):1717-23. PubMed ID: 24124001
[TBL] [Abstract][Full Text] [Related]
13. A novel PAK4-CEBPB-CLDN4 axis involving in breast cancer cell migration and invasion.
Wang F; Gao Y; Tang L; Ning K; Geng N; Zhang H; Li Y; Li Y; Liu F; Li F
Biochem Biophys Res Commun; 2019 Apr; 511(2):404-408. PubMed ID: 30808546
[TBL] [Abstract][Full Text] [Related]
14. α4 contributes to bladder urothelial carcinoma cell invasion and/or metastasis via regulation of E-cadherin and is a predictor of outcome in bladder urothelial carcinoma patients.
Liu J; Cai M; Chen J; Liao Y; Mai S; Li Y; Huang X; Liu Y; Zhang J; Kung H; Zeng Y; Zhou F; Xie D
Eur J Cancer; 2014 Mar; 50(4):840-51. PubMed ID: 24388773
[TBL] [Abstract][Full Text] [Related]
15. CLDN4 silencing promotes proliferation and reduces chemotherapy sensitivity of gastric cancer cells through activation of the PI3K/Akt signalling pathway.
Luo J; Wang H; Chen H; Gan G; Zheng Y
Exp Physiol; 2020 Jun; 105(6):979-988. PubMed ID: 31856376
[TBL] [Abstract][Full Text] [Related]
16. Role of
Fujiwara-Tani R; Fujii K; Mori S; Kishi S; Sasaki T; Ohmori H; Nakashima C; Kawahara I; Nishiguchi Y; Mori T; Sho M; Kondoh M; Luo Y; Kuniyasu H
Int J Mol Sci; 2020 May; 21(11):. PubMed ID: 32481659
[TBL] [Abstract][Full Text] [Related]
17. Zinc finger protein 703 induces EMT and sorafenib resistance in hepatocellular carcinoma by transactivating CLDN4 expression.
Wang H; Xu H; Ma F; Zhan M; Yang X; Hua S; Li W; Li Y; Lu L
Cell Death Dis; 2020 Apr; 11(4):225. PubMed ID: 32269215
[TBL] [Abstract][Full Text] [Related]
18. Genome-wide DNA methylation identifies trophoblast invasion-related genes: Claudin-4 and Fucosyltransferase IV control mobility via altering matrix metalloproteinase activity.
Hu Y; Blair JD; Yuen RK; Robinson WP; von Dadelszen P
Mol Hum Reprod; 2015 May; 21(5):452-65. PubMed ID: 25697377
[TBL] [Abstract][Full Text] [Related]
19. Claudin-4 controls the receptor tyrosine kinase EphA2 pro-oncogenic switch through β-catenin.
Shang X; Lin X; Howell SB
Cell Commun Signal; 2014 Oct; 12():59. PubMed ID: 25344320
[TBL] [Abstract][Full Text] [Related]
20. Targeting claudin-4 enhances chemosensitivity in breast cancer.
Luo Y; Kishi S; Sasaki T; Ohmori H; Fujiwara-Tani R; Mori S; Goto K; Nishiguchi Y; Mori T; Kawahara I; Kondoh M; Kuniyasu H
Cancer Sci; 2020 May; 111(5):1840-1850. PubMed ID: 32086991
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]